C3 and neuromyelitis optica: In conclusion, our findings for the first time analyzed the clinical symptoms of brain involvement and MRI characteristics of NMO with EBLs and found the changes of inflammation markers (CRP and ESR) and complement (including C3, C4, and CH50) took place obviously in the NMO with EBLs compared to the NMO patients without EBLs.